XK and influenza: Even though many efforts including a universal influenza vaccine [30], non-egg cell lines [31,32], genetically engineered viruses with egg-adapted neuraminidase (NA) [33,34] and DNA vaccines [4] have been explored to improve vaccine efficacy, the transition to newer technologies [35] will likely progress rather slowly due to economic and technological limitations.